封面
市场调查报告书
商品编码
1448795

全球医疗保健市场生成人工智慧研究报告 - 2024 年至 2032 年行业分析、规模、份额、成长、趋势和预测

Global Generative AI in Healthcare Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日期: | 出版商: Value Market Research | 英文 152 Pages | 商品交期: 最快1-2个工作天内

价格

全球医疗保健市场对产生人工智慧的需求预计将从 2023 年的 26 亿美元达到近 341.3 亿美元的市场规模,2024 年至 2032 年的研究期间CAGR为 33.12%。

医疗保健中的生成式人工智慧是产生模型的应用,以在医疗保健和医疗应用的背景下创建新的、真实的资料或内容。生成式人工智慧模型,特别是生成式对抗网路(GAN)和其他类似的架构,旨在产生模仿它们所训练的输入资料的模式和特征的资料。

市场动态

医疗保健市场中的生成式人工智慧受到多种因素的推动,这些因素凸显了人工智慧技术在医疗保健领域的日益一体化。关键驱动因素包括该技术透过资料增强解决资料挑战的能力,特别是在产生多样化和代表性数据集方面。生成式人工智慧透过产生用于诊断模型训练的逼真图像并提高准确性来帮助推进医学成像。在药物发现中,该技术透过生成新颖的分子结构和候选药物来加快此过程。治疗计划的个人化和为决策支援创建现实的临床场景有助于其采用。保护隐私的资料产生、疾病预测模拟和产业合作也推动了市场成长。此外,COVID-19 大流行的影响加速了生成式 AI 在医疗保健领域的采用,特别是在医学影像分析和药物发现等任务中。运算能力和监管支援的不断进步进一步促进了这个充满活力的市场的扩张。

研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外,这些工具也对全球医疗保健生成人工智慧市场的各个细分市场进行了包容性评估。医疗保健产业中生成式人工智慧的成长和趋势为这项研究提供了整体方法。

市场区隔

医疗保健市场报告中的生成人工智慧部分提供了国家和地区层面细分市场的详细资料,从而帮助策略家确定相应产品或服务的目标人群以及即将到来的机会。

按应用

  • 个人化治疗
  • 病人协助
  • 患者监测和预测分析
  • 医学影像分析与诊断
  • 药物发现与开发
  • 其他

按最终用途

  • 医疗保健提供者(医院、诊所、诊断中心、其他医疗保健提供者)
  • 製药和生命科学公司
  • 医疗保健支付者

区域分析

本节涵盖区域前景,重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲医疗保健市场中产生人工智慧当前和未来的需求。此外,该报告重点关注所有主要地区各个应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。医疗保健市场产生人工智慧的主要参与者包括 Epic Systems Corporation、DiagnaMed Holdings Corp.、Syntegra Medical Mind、IBM Watson Health Corporation、Google LLC、Oracle Corporation、Microsoft Corporation、Nvidia Corporation、Insilico Medicine、Abridge AI Inc.、 ELEKS ,持久系统。本节包含竞争格局的整体视图,包括各种策略发展,例如关键併购、未来产能、合作伙伴关係、财务概况、合作、新产品开发、新产品发布和其他发展。

如果您有任何客製化要求,请写信给我们。我们的研究团队可以根据您的需求提供客製化报告。

目录

第一章:前言

  • 报告说明
    • 客观的
    • 目标受众
    • 独特的销售主张 (USP) 和产品
  • 研究范围
  • 研究方法论
    • 市场研究过程
    • 市场研究方法论

第 2 章:执行摘要

  • 市集亮点
  • 全球市场概况

第 3 章:医疗保健中的生成人工智慧 - 产业分析

  • 简介 - 市场动态
  • 市场驱动因素
  • 市场限制
  • 机会
  • 产业动态
  • 波特五力分析
  • 市场吸引力分析
    • 市场吸引力分析:依应用分类
    • 按最终用途分類的市场吸引力分析
    • 市场吸引力分析:按地区

第 4 章:价值链分析

  • 价值链分析
  • 原料分析
    • 原料清单
    • 原料厂商清单
    • 主要原物料价格走势
  • 潜在买家名单
  • 行销管道
    • 直效行销
    • 间接行销
    • 行销通路发展趋势

第 5 章:全球医疗保健市场中的生成人工智慧分析:按应用分类

  • 概述:按应用
  • 历史和预测数据
  • 分析:按应用
  • 个人化治疗
  • 病人协助
  • 患者监测和预测分析
  • 医学影像分析与诊断
  • 药物发现与开发
  • 其他

第 6 章:全球医疗保健市场中的生成人工智慧分析:按最终用途分类

  • 按最终用途分類的概述
  • 历史和预测数据
  • 按最终用途分析
  • 医疗保健提供者(医院、诊所、诊断中心、其他医疗保健提供者)
  • 製药和生命科学公司
  • 医疗保健支付者

第 7 章:全球医疗保健市场中的生成人工智慧分析:按地理位置

  • 区域展望
  • 介绍
  • 北美销售分析
    • 概览、历史与预测资料销售分析
    • 北美按细分市场销售分析
    • 北美按国家销售分析
    • 美国销售分析
    • 加拿大销售分析
    • 墨西哥销售分析
  • 欧洲销售分析
    • 概览、历史与预测资料销售分析
    • 欧洲按细分市场销售分析
    • 欧洲按国家销售分析
    • 英国销售分析
    • 法国销售分析
    • 德国销售分析
    • 义大利销售分析
    • 俄罗斯销售分析
    • 欧洲其他地区销售分析
  • 亚太地区销售分析
    • 概览、历史与预测资料销售分析
    • 亚太地区按细分市场销售分析
    • 亚太地区国家/地区销售分析
    • 中国销售分析
    • 印度销售分析
    • 日本销售分析
    • 韩国销售分析
    • 澳洲销售分析
    • 东南亚销售分析
    • 亚太地区其他地区销售分析
  • 拉丁美洲销售分析
    • 概览、历史与预测资料销售分析
    • 拉丁美洲按细分市场销售分析
    • 拉丁美洲按国家销售分析
    • 巴西销售分析
    • 阿根廷销售分析
    • 秘鲁销售分析
    • 智利销售分析
    • 拉丁美洲其他地区销售分析
  • 中东和非洲销售分析
    • 概览、历史与预测资料销售分析
    • 中东和非洲按细分市场销售分析
    • 中东和非洲国家销售分析
    • 沙乌地阿拉伯销售分析
    • 阿联酋销售分析
    • 以色列销售分析
    • 南非销售分析
    • 中东其他地区和非洲销售分析

第 8 章:医疗保健公司中生成式人工智慧的竞争格局

  • 医疗保健市场竞争中的生成人工智慧
  • 伙伴关係/协作/协议
  • 併购
  • 新产品发布
  • 其他发展

第 9 章:公司简介

  • 顶级公司市占率分析
  • 市场集中度
  • Epic Systems Corporation
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • DiagnaMed Holdings Corp.,
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Syntegra Medical Mind
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • IBM Watson Health Corporation
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Google LLC
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Oracle Corporation
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Microsoft Corporation
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Nvidia Corporation
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Insilico Medicine
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Abridge AI Inc.
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • ELEKS
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Persistent Systems
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展

注意 - 在公司概况中,财务详细资讯和近期发展视情况而定,或者如果是私人公司,则可能不包括在内

Product Code: VMR112113545

The global demand for Generative AI in Healthcare Market is presumed to reach the market size of nearly USD 34.13 Billion by 2032 from USD 2.6 Billion in 2023 with a CAGR of 33.12% under the study period 2024 - 2032.

Generative AI in healthcare is the application of generative models to create new and realistic data or content in the context of healthcare and medical applications. Generative AI models, particularly generative adversarial networks (GANs) and other similar architectures are designed to generate data that mimics the patterns and characteristics of the input data they were trained on.

MARKET DYNAMICS

Generative AI in the healthcare market is propelled by various factors that highlight the increasing integration of AI technologies in the healthcare sector. Key drivers include the technology's ability to address data challenges through data augmentation, particularly in the generation of diverse and representative datasets. Generative AI assists in advancing medical imaging by generating realistic images for diagnostic model training and enhancing accuracy. In drug discovery, the technology expedites the process by generating novel molecular structures and drug candidates. The personalization of treatment plans and the creation of realistic clinical scenarios for decision support contribute to its adoption. Privacy-preserving data generation, disease prediction simulations, and industry collaborations also drive market growth. Furthermore, the impact of the COVID-19 pandemic has accelerated the adoption of Generative AI in healthcare, particularly in tasks such as medical imaging analysis and drug discovery. Continuous advancements in computational capabilities and regulatory support further contribute to the expansion of this dynamic market.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of generative ai in healthcare. The growth and trends of generative ai in healthcare industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the generative ai in healthcare market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Application

  • Personalized Treatment
  • Patient Assistance
  • Patient Monitoring And Predictive Analytics
  • Medical Image Analysis And Diagnostics
  • Drug Discovery And Development
  • Other

By End-Use

  • Healthcare Providers (Hospitals, Clinics, Diagnostic Centers, Other Healthcare Providers)
  • Pharmaceutical And Life Sciences Companies
  • Healthcare Payers

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Generative AI in Healthcare market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Generative AI in Healthcare market include Epic Systems Corporation, DiagnaMed Holdings Corp.,, Syntegra Medical Mind, IBM Watson Health Corporation, Google LLC, Oracle Corporation, Microsoft Corporation, Nvidia Corporation, Insilico Medicine, Abridge AI Inc., ELEKS, Persistent Systems. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

  • 1.1. Report Description
    • 1.1.1. Objective
    • 1.1.2. Target Audience
    • 1.1.3. Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3 . GENERATIVE AI IN HEALTHCARE - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Application
    • 3.7.2 Market Attractiveness Analysis By End-use
    • 3.7.3 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1. List of Raw Materials
    • 4.2.2. Raw Material Manufactures List
    • 4.2.3. Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1. Direct Marketing
    • 4.4.2. Indirect Marketing
    • 4.4.3. Marketing Channel Development Trend

5 . GLOBAL GENERATIVE AI IN HEALTHCARE MARKET ANALYSIS BY APPLICATION

  • 5.1 Overview by Application
  • 5.2 Historical and Forecast Data
  • 5.3 Analysis by Application
  • 5.4 Personalized Treatment Historic and Forecast Sales by Regions
  • 5.5 Patient Assistance Historic and Forecast Sales by Regions
  • 5.6 Patient Monitoring And Predictive Analytics Historic and Forecast Sales by Regions
  • 5.7 Medical Image Analysis And Diagnostics Historic and Forecast Sales by Regions
  • 5.8 Drug Discovery And Development Historic and Forecast Sales by Regions
  • 5.9 Other Historic and Forecast Sales by Regions

6 . GLOBAL GENERATIVE AI IN HEALTHCARE MARKET ANALYSIS BY END-USE

  • 6.1 Overview by End-use
  • 6.2 Historical and Forecast Data
  • 6.3 Analysis by End-use
  • 6.4 Healthcare Providers (Hospitals, Clinics, Diagnostic Centers, Other Healthcare Providers) Historic and Forecast Sales by Regions
  • 6.5 Pharmaceutical And Life Sciences Companies Historic and Forecast Sales by Regions
  • 6.6 Healthcare Payers Historic and Forecast Sales by Regions

7 . GLOBAL GENERATIVE AI IN HEALTHCARE MARKET ANALYSIS BY GEOGRAPHY

  • 7.1. Regional Outlook
  • 7.2. Introduction
  • 7.3. North America Sales Analysis
    • 7.3.1. Overview, Historic and Forecast Data Sales Analysis
    • 7.3.2. North America By Segment Sales Analysis
    • 7.3.3. North America By Country Sales Analysis
    • 7.3.4. United State Sales Analysis
    • 7.3.5. Canada Sales Analysis
    • 7.3.6. Mexico Sales Analysis
  • 7.4. Europe Sales Analysis
    • 7.4.1. Overview, Historic and Forecast Data Sales Analysis
    • 7.4.2. Europe by Segment Sales Analysis
    • 7.4.3. Europe by Country Sales Analysis
    • 7.4.4. United Kingdom Sales Analysis
    • 7.4.5. France Sales Analysis
    • 7.4.6. Germany Sales Analysis
    • 7.4.7. Italy Sales Analysis
    • 7.4.8. Russia Sales Analysis
    • 7.4.9. Rest Of Europe Sales Analysis
  • 7.5. Asia Pacific Sales Analysis
    • 7.5.1. Overview, Historic and Forecast Data Sales Analysis
    • 7.5.2. Asia Pacific by Segment Sales Analysis
    • 7.5.3. Asia Pacific by Country Sales Analysis
    • 7.5.4. China Sales Analysis
    • 7.5.5. India Sales Analysis
    • 7.5.6. Japan Sales Analysis
    • 7.5.7. South Korea Sales Analysis
    • 7.5.8. Australia Sales Analysis
    • 7.5.9. South East Asia Sales Analysis
    • 7.5.10. Rest Of Asia Pacific Sales Analysis
  • 7.6. Latin America Sales Analysis
    • 7.6.1. Overview, Historic and Forecast Data Sales Analysis
    • 7.6.2. Latin America by Segment Sales Analysis
    • 7.6.3. Latin America by Country Sales Analysis
    • 7.6.4. Brazil Sales Analysis
    • 7.6.5. Argentina Sales Analysis
    • 7.6.6. Peru Sales Analysis
    • 7.6.7. Chile Sales Analysis
    • 7.6.8. Rest of Latin America Sales Analysis
  • 7.7. Middle East & Africa Sales Analysis
    • 7.7.1. Overview, Historic and Forecast Data Sales Analysis
    • 7.7.2. Middle East & Africa by Segment Sales Analysis
    • 7.7.3. Middle East & Africa by Country Sales Analysis
    • 7.7.4. Saudi Arabia Sales Analysis
    • 7.7.5. UAE Sales Analysis
    • 7.7.6. Israel Sales Analysis
    • 7.7.7. South Africa Sales Analysis
    • 7.7.8. Rest Of Middle East And Africa Sales Analysis

8 . COMPETITIVE LANDSCAPE OF THE GENERATIVE AI IN HEALTHCARE COMPANIES

  • 8.1. Generative Ai In Healthcare Market Competition
  • 8.2. Partnership/Collaboration/Agreement
  • 8.3. Merger And Acquisitions
  • 8.4. New Product Launch
  • 8.5. Other Developments

9 . COMPANY PROFILES OF GENERATIVE AI IN HEALTHCARE INDUSTRY

  • 9.1. Top Companies Market Share Analysis
  • 9.2. Market Concentration Rate
  • 9.3. Epic Systems Corporation
    • 9.3.1. Company Overview
    • 9.3.2. Company Revenue
    • 9.3.3. Products
    • 9.3.4. Recent Developments
  • 9.4. DiagnaMed Holdings Corp.,
    • 9.4.1. Company Overview
    • 9.4.2. Company Revenue
    • 9.4.3. Products
    • 9.4.4. Recent Developments
  • 9.5. Syntegra Medical Mind
    • 9.5.1. Company Overview
    • 9.5.2. Company Revenue
    • 9.5.3. Products
    • 9.5.4. Recent Developments
  • 9.6. IBM Watson Health Corporation
    • 9.6.1. Company Overview
    • 9.6.2. Company Revenue
    • 9.6.3. Products
    • 9.6.4. Recent Developments
  • 9.7. Google LLC
    • 9.7.1. Company Overview
    • 9.7.2. Company Revenue
    • 9.7.3. Products
    • 9.7.4. Recent Developments
  • 9.8. Oracle Corporation
    • 9.8.1. Company Overview
    • 9.8.2. Company Revenue
    • 9.8.3. Products
    • 9.8.4. Recent Developments
  • 9.9. Microsoft Corporation
    • 9.9.1. Company Overview
    • 9.9.2. Company Revenue
    • 9.9.3. Products
    • 9.9.4. Recent Developments
  • 9.10. Nvidia Corporation
    • 9.10.1. Company Overview
    • 9.10.2. Company Revenue
    • 9.10.3. Products
    • 9.10.4. Recent Developments
  • 9.11. Insilico Medicine
    • 9.11.1. Company Overview
    • 9.11.2. Company Revenue
    • 9.11.3. Products
    • 9.11.4. Recent Developments
  • 9.12. Abridge AI Inc.
    • 9.12.1. Company Overview
    • 9.12.2. Company Revenue
    • 9.12.3. Products
    • 9.12.4. Recent Developments
  • 9.13. ELEKS
    • 9.13.1. Company Overview
    • 9.13.2. Company Revenue
    • 9.13.3. Products
    • 9.13.4. Recent Developments
  • 9.14. Persistent Systems
    • 9.14.1. Company Overview
    • 9.14.2. Company Revenue
    • 9.14.3. Products
    • 9.14.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers : Impact Analysis
  • Restraints : Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • Analysis by Application (USD MN)
  • Personalized Treatment Market Sales by Geography (USD MN)
  • Patient Assistance Market Sales by Geography (USD MN)
  • Patient Monitoring And Predictive Analytics Market Sales by Geography (USD MN)
  • Medical Image Analysis And Diagnostics Market Sales by Geography (USD MN)
  • Drug Discovery And Development Market Sales by Geography (USD MN)
  • Other Market Sales by Geography (USD MN)
  • Analysis Market by End-use (USD MN)
  • Healthcare Providers (Hospitals, Clinics, Diagnostic Centers, Other Healthcare Providers) Market Sales by Geography (USD MN)
  • Pharmaceutical And Life Sciences Companies Market Sales by Geography (USD MN)
  • Healthcare Payers Market Sales by Geography (USD MN)
  • Global Generative Ai In Healthcare Market Sales by Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United State Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate by Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Generative Ai In Healthcare Report
  • Market Research Process
  • Market Research Methodology
  • Global Generative Ai In Healthcare Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Application
  • Market Attractiveness Analysis by End-use
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Market Analysis by Application (USD MN)
  • Personalized Treatment Market Sales by Geography (USD MN)
  • Patient Assistance Market Sales by Geography (USD MN)
  • Patient Monitoring And Predictive Analytics Market Sales by Geography (USD MN)
  • Medical Image Analysis And Diagnostics Market Sales by Geography (USD MN)
  • Drug Discovery And Development Market Sales by Geography (USD MN)
  • Other Market Sales by Geography (USD MN)
  • Global Market Analysis by End-use (USD MN)
  • Healthcare Providers (Hospitals, Clinics, Diagnostic Centers, Other Healthcare Providers) Market Sales by Geography (USD MN)
  • Pharmaceutical And Life Sciences Companies Market Sales by Geography (USD MN)
  • Healthcare Payers Market Sales by Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Companies Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.